Related Experiment Video
Updated: Jan 18, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Multiomics Integration and Machine Learning Reveal Colony Stimulating Factor 3 Receptor as a Key Gene and Therapeutic
Peihong Li1, Hongyi Hu1, Lujia Yang1
1Department of Gastroenterology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Researchers identified CSF3R as a key gene in Crohn's disease (CD) pathogenesis. This finding offers potential for improved diagnostics and targeted therapies for this chronic inflammatory condition.
Area of Science:
- Immunology and Genetics
- Molecular Biology
Background:
- Crohn's disease (CD) is a chronic inflammatory condition with complex immune dysregulation.
- Identifying key molecular drivers is crucial for advancing diagnostic and therapeutic strategies in CD.
Purpose of the Study:
- To identify key molecular drivers in Crohn's disease using integrated transcriptomic data and machine learning.
- To investigate the role of CSF3R in CD pathogenesis and its potential as a diagnostic and therapeutic target.
Main Methods:
- Integrated transcriptomic data analysis using Random Forest, SVM-RFE, and LASSO algorithms.
- Mendelian randomization (MR) analysis to assess the causal role of CSF3R.
- Single-cell RNA sequencing, immune infiltration analysis, qPCR, Western blot, immunohistochemistry, and molecular docking for validation.
Main Results:
- CSF3R was identified as a top candidate gene causally linked to CD pathogenesis (OR = 1.400).
- Elevated CSF3R expression was observed in neutrophils, associated with neutrophil-mediated inflammation.
- Experimental validation confirmed significantly upregulated CSF3R mRNA and protein levels in CD patients; high diagnostic performance (AUC 0.823-0.938) was achieved.
Conclusions:
- CSF3R is a robust diagnostic biomarker for Crohn's disease.
- CSF3R represents a promising therapeutic target, with potential binding affinity to agents like methotrexate and aspirin.
- These findings provide mechanistic insights and support precision medicine approaches for CD.
More Related Videos
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids